Gerry Smith

Moderna shares fell as much as 14 percent in Monday trading, while other makers of vaccines and drugs like gene therapies saw their stocks drop, including Novavax, BioNTech, and Sarepta Therapeutics.

Drug manufacturers are rushing to reshape their supply chains amid President Donald Trump’s escalating tariff threats, leading to a potential windfall for contractors that make medications in the US.

The Trump administration’s move to gut the agency tasked with ensuring workplace safety is facing intensifying pushback, including from the nation’s largest auto union and a conservative lawmaker, in one of the more prominent public fights against some of the widespread cuts last week.

(Bloomberg) — Drug manufacturers are rushing to reshape their supply chains amid President Donald Trump's escalating tariff threats, leading to a potential windfall for contractors that make medications in the US.

(Bloomberg) -- Shares of vaccine makers fell after US Health and Human Services Secretary Robert F.

Verve Therapeutics Inc. shares jumped after the company reported no safety issues in a new study of its gene-editing treatment for people with high cholesterol.

A group of embattled government advisers will meet this week in the first major test of who controls US vaccine policy: scientific experts or Robert F. Kennedy Jr.

Verve Therapeutics Inc. shares jumped after the company reported no safety issues in a new study of its gene-editing treatment for people with high cholesterol.

(Bloomberg) -- A group of embattled government advisers will meet this week in the first major test of who controls US vaccine policy: scientific experts or Robert F.

A key group of government advisers voted to expand the use of vaccines for a common respiratory illness, providing a boost to manufacturers whose sales fell sharply last year.